Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Obalon Therapeutics Inc (OBLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9400
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gastric balloon for weight loss therapy. Obalon Therapeutics’ Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity. The company’s Obalon balloon system is also designed to provide weight loss in obese patients with combined with diet and exercise. It offers its products through its distributors located across the US, Obalon Therapeutics is headquartered in Carlsbad, California, the US.

Obalon Therapeutics Inc (OBLN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 10
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 11
Obalon Therapeutics Prices IPO for USD75 Million 13
Obalon Therapeutics Inc – Key Competitors 15
Obalon Therapeutics Inc – Key Employees 16
Obalon Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Aug 02, 2018: Obalon Announces Second Quarter 2018 Financial Results 18
May 10, 2018: Obalon Announces First Quarter 2018 Financial Results 19
Mar 05, 2018: Obalon Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results 20
Jan 05, 2018: Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017 21
Nov 03, 2017: Obalon Announces Third Quarter 2017 Financial Results 22
Aug 02, 2017: Obalon Announces Second Quarter 2017 Financial Results 23
May 10, 2017: Obalon Announces First Quarter 2017 Financial Results 24
Feb 23, 2017: Obalon Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results 25
Corporate Communications 26
Sep 07, 2017: Kelly Huang, Ph.D., Joins Obalon Therapeutics Executive Team 26
Jan 17, 2017: Jonah Shacknai Joins Obalon Therapeutics Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Obalon Therapeutics Plans to Raise Funds through Public Offering of Shares 10
Obalon Therapeutics Raises USD10 Million in Private Placement of Shares 11
Obalon Therapeutics Prices IPO for USD75 Million 13
Obalon Therapeutics Inc, Key Competitors 15
Obalon Therapeutics Inc, Key Employees 16

List of Figures
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Obalon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Obalon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rhenus SE & Co KG:企業のM&A・事業提携・投資動向
    Rhenus SE & Co KG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rhenus SE & Co KG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Sime Darby Berhad (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Berhad (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Georgia Power Co:企業の戦略的SWOT分析
    Georgia Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Alawwal Bank:企業の戦略・SWOT・財務情報
    Alawwal Bank - Strategy, SWOT and Corporate Finance Report Summary Alawwal Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • VirTra Inc (VTSI):企業の財務・戦略的SWOT分析
    VirTra Inc (VTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Total Energy Services Inc (TOT):石油・ガス:M&Aディール及び事業提携情報
    Summary Total Energy Services Inc (Total Energy) is an energy services company. It offers contract drilling services and rental and transportation services for equipment utilized in drilling, completion and production activities in oil and gas wells. The company also provides fabrication, sale, rent …
  • CG Power and Industrial Solutions Ltd (CGPOWER):企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Seaboard Corp (SEB):企業の財務・戦略的SWOT分析
    Seaboard Corp (SEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Genuine Parts Company:戦略・SWOT・企業財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DN …
  • QuickLogic Corp (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corp (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Medicilon Inc (Medicilon) is a drug discovery company that offers integrated services across biology, preclinical, chemistry, and drug discovery processes. The company provides chemistry services such as process development, medicinal chemistry, synthesis chemistry, and analytical c …
  • VivaCell Biotechnology Espana SL:製薬・医療:M&Aディール及び事業提携情報
    Summary VivaCell Biotechnology Espana SL (VivaCell Biotechnology), a subsidiary of VivaCell Biotechnology GmbH, is a preclinical-stage pharmaceutical company that develops medicinal derivatives. The company's products comprise CDE-001, VCE-003.2 and VCE-004.8. It provides research and development, c …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • LifeArc:企業のM&A・事業提携・投資動向
    LifeArc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LifeArc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Randstad Holding nv:企業の戦略・SWOT・財務分析
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆